Live-Cell Surface Proteomic Characterization of Atypical Teratoid Rhabdoid Tumors Using High Throughout Multi-Color Flow |
University of Colorado Denver / Siddhartha S. Mitra, PhD |
Crazy 8 Pilots |
2019 |
Colorado |
Targeting Eya2 to Inhibit c-Myc driven Medulloblastoma Tumor Progression |
University of Colorado Denver / Melanie Vincent, PhD |
Young Investigator Grants |
2016 |
Colorado |
MicroRNAs 100 and 125b in Ewing sarcoma |
University of Colorado Denver / Paul Jedlicka |
Young Investigator Grants |
2010 |
Colorado |
Expanding Access to New Agents for Cancer Treatment.
|
Children’s Hospital Colorado / Lia Gore, MD |
Phase I/II Infrastructure Grants |
2006 |
Colorado |
Expanding access to new agents for children with refractory cancers: the experimental therapeutics program at Children's Hospital of Colorado.
|
Children’s Hospital Colorado / Lia Gore, MD |
Phase I/II Infrastructure Grants |
2009 |
Colorado |
A Novel Adjunctive LAT-Activating CART (ALA-CART) Cell Platform for the Treatment of Acute Leukemia |
University of Colorado Denver_ Anschutz Medical Campus / Catherine Danis, PhD |
Young Investigator Grants |
2023 |
Colorado |
Exploiting Epigenetic Dependencies of Notch1 for Clinical Benefit |
University of Colorado Denver / Patricia Ernst, Ph.D. |
Innovation Grants |
2014 |
Colorado |
Advancing Program Development and Support for the Pediatric Experimental Therapeutics Program at The Children's Hospital, Denver
|
Children’s Hospital Colorado / Lia Gore, MD |
Phase I/II Infrastructure Grants |
2007 |
Colorado |
Development of a Novel Mer Tyrosine Kinase Inhibitor for Treatment of ALL |
University of Colorado Denver / Doug Graham, MD, PhD |
Reach Grants |
2013 |
Colorado |
Targeting the Six1/Eya Transcriptional Complex to Inhibit Pediatric Sarcomas |
University of Colorado Denver / Heide Ford, Ph.D. |
Innovation Grants |
2014 |
Colorado |